Max Lab > Lab Test in Bengaluru > Lab Test in Doddakallasandra > MRD-ALL Panel
₹ 12500
25% OFF ON ABOVE PRICE | USE CODE ML25 *
@3x.png)
Description
Minimal residual disease is defined as the small number of cancer cells that remain in the body after cancer treatment. Measurable or minimal residual disease (MRD) testing is used to observe whether the cancer treatment is working fine or not. It also helps to plan further treatment plans. MRD test in Doddakallasandra, Bengaluruing is mainly used in blood cancers, such as leukaemia, lymphoma, and myeloma. MRD test in Doddakallasandra, Bengaluru for acute leukaemia is the strongest independent prognostic predictor. Also, for the treatment of adult and paediatric acute lymphocytic leukaemia (ALL), MRD test in Doddakallasandra, Bengaluruing is a part of routine test in Doddakallasandra, Bengaluruing. Additionally, in relapsed settings of multiple myeloma, MRD test in Doddakallasandra, Bengaluruing is a predictor of survival outcomes. The standard procedure of the MRD test in Doddakallasandra, Bengaluru is to assess the number of myeloma cells in a bone marrow sample using techniques like genetic sequence analysis, next-generation sequencing and flow cytometry: next-generation flow.
MRD test in Doddakallasandra, Bengaluru is done to find any remaining cancer cells that may be left in small numbers. MRD lab test in Doddakallasandra, Bengalurus use sensitive methods which can find even a single cancer cell in 1 million healthy cells. MRD blood test in Doddakallasandra, Bengalurus include methods such as polymerase chain reaction (PCR), multiparametric flow cytometry, and next-generation sequencing (NGS). Such test in Doddakallasandra, Bengalurus are used after initial treatments for blood cancers like multiple myeloma. It helps to observe how well a person’s body is responding to treatment, if the person is in full remission, and to check if remission is stable or not or if there is any recurrence.
MRD test in Doddakallasandra, Bengaluru results can affect a person’s treatment by helping in making treatment decisions and improving patient outcomes as it helps in:
Description
Minimal residual disease is defined as the small number of cancer cells that remain in the body after cancer treatment. Measurable or minimal residual disease (MRD) testing is used to observe whether the cancer treatment is working fine or not. It also helps to plan further treatment plans. MRD test in Doddakallasandra, Bengaluruing is mainly used in blood cancers, such as leukaemia, lymphoma, and myeloma. MRD test in Doddakallasandra, Bengaluru for acute leukaemia is the strongest independent prognostic predictor. Also, for the treatment of adult and paediatric acute lymphocytic leukaemia (ALL), MRD test in Doddakallasandra, Bengaluruing is a part of routine test in Doddakallasandra, Bengaluruing. Additionally, in relapsed settings of multiple myeloma, MRD test in Doddakallasandra, Bengaluruing is a predictor of survival outcomes. The standard procedure of the MRD test in Doddakallasandra, Bengaluru is to assess the number of myeloma cells in a bone marrow sample using techniques like genetic sequence analysis, next-generation sequencing and flow cytometry: next-generation flow.
MRD test in Doddakallasandra, Bengaluru is done to find any remaining cancer cells that may be left in small numbers. MRD lab test in Doddakallasandra, Bengalurus use sensitive methods which can find even a single cancer cell in 1 million healthy cells. MRD blood test in Doddakallasandra, Bengalurus include methods such as polymerase chain reaction (PCR), multiparametric flow cytometry, and next-generation sequencing (NGS). Such test in Doddakallasandra, Bengalurus are used after initial treatments for blood cancers like multiple myeloma. It helps to observe how well a person’s body is responding to treatment, if the person is in full remission, and to check if remission is stable or not or if there is any recurrence.
MRD test in Doddakallasandra, Bengaluru results can affect a person’s treatment by helping in making treatment decisions and improving patient outcomes as it helps in:
Advances in medical technology have made it possible for doctors to gain valu...Read More
Congenital adrenal hyperplasia (CAH) refers to a group of ge...Read More
Neurofibromatosis (NF) is a genetic tumour that primarily af...Read More
What is Hydrocephalus? Hydrocephalus...Read More
.png)
7982100200
Test Name 
Sample Type 
Gender 
Age group 
This Test Includes 
Price
To reach our help desk call 9213188888